Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Dyspepsia and Gastro-oesophageal Reflux Disease Guidelines, Schemes and Mind Maps of Nursing

Guidelines for the investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both. It includes recommendations for testing for h. Pylori, choosing proton pump inhibitors, and managing nsaid-induced ulcers. It also discusses the risks of long-term ppi use and the importance of lifestyle modifications.

Typology: Schemes and Mind Maps

2021/2022

Uploaded on 09/27/2022

riciard
riciard 🇬🇧

4.4

(7)

234 documents

1 / 3

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
“ALARMS
Anaemia
Loss of weight
Anorexia
Recurrent symptoms
(dysphagia, odynophagia)
Persistent continuous
vomiting
Epigastric mass
GI bleed/ melaena
Previous gastric surgery
Progressive swallowing
problems (dysphagia)
Urgent referral to
G.I. Consultant
Positive
H.pylori
eradication
therapy as per
BNF one week
course is
recommended
Persistent or
recurrent
symptoms
refer for
endoscopy
Negative
aluminium /
magnesium
mixture eg
Maalox Plus®
Ranitidine
Low dose PPI
Lifestyle advice
GORD
Mild alginate
suspension
Severe
lansoprazole or
omeprazole
Dyspepsia Guidelines
Recent onset
dyspepsia
Under 55 years
Test for H. pylori using stool
antigen test (preferred
option),
serology or urea breath test
No Alarm symptoms
Over 55 years -
Refer for endoscopy
Abnormal
Appropriate
treatment or
further
referral
Normal
treat as for
under 55
years and H.
pylori
negative
Additional Information on PPIs
PPIs are over-prescribed.
Many patients can be adequately treated
with a cost effective alginate such as Peptac
Patients should have a documented and
appropriate indication for receiving a PPI
PPIs suppress gastric acid and cause
bacterial overgrowth eg with C difficile
Long-term use of PPIs can cause
temporary problems of rebound
hyperacidity on withdrawal
Increased risk of hip fracture with long-
term PPI use
If NSAID treatment is essential and the
patient has an ulcer, prescribe the
treatment dose of omeprazole or
lansoprazole (cost effective options)
If NSAID treatment must continue and the
patient has non-ulcer dyspepsia, use a
maintenance PPI dose
When Not to Refer for Endoscopy
Aged under 55 years and no alarm
signs
Not yet tested for H. pylori and
treated, if necessary
Recent normal endoscopy result but
persistent symptoms
Long established dyspepsia that has
not become worse over a period of
time
NB
Most GI ulcers are strongly
associated with H. pylori infection
30% of endoscopy results are normal
2% diagnose oesophago/gastric
cancer
Endoscopy is expensive
pf3

Partial preview of the text

Download Dyspepsia and Gastro-oesophageal Reflux Disease Guidelines and more Schemes and Mind Maps Nursing in PDF only on Docsity!

“ALARMS”

Anaemia Loss of weight Anorexia Recurrent symptoms (dysphagia, odynophagia) Persistent continuous vomiting Epigastric mass GI bleed/ melaena Previous gastric surgery Progressive swallowing problems (dysphagia)

Urgent referral to

G.I. Consultant

Positive – H.pylori eradication therapy as per BNF – one week course is recommended

Persistent or recurrent symptoms – refer for endoscopy

Negative – aluminium / magnesium mixture eg Maalox Plus® Ranitidine Low dose PPI Lifestyle advice

GORD

Mild – alginate suspension Severe – lansoprazole or omeprazole

Dyspepsia Guidelines

Recent onset dyspepsia

Under 55 years – Test for H. pylori using stool antigen test (preferred option), serology or urea breath test

No Alarm symptoms

Over 55 years - Refer for endoscopy

Abnormal – Appropriate treatment or further referral

Normal – treat as for under 55 years and H. pylori negative

Additional Information on PPIs

  • PPIs are over-prescribed.
  • Many patients can be adequately treated

with a cost effective alginate such as Peptac

  • Patients should have a documented and

appropriate indication for receiving a PPI

  • PPIs suppress gastric acid and cause

bacterial overgrowth eg with C difficile

  • Long-term use of PPIs can cause

temporary problems of rebound

hyperacidity on withdrawal

  • Increased risk of hip fracture with long-

term PPI use

  • If NSAID treatment is essential and the

patient has an ulcer, prescribe the

treatment dose of omeprazole or

lansoprazole (cost effective options)

  • If NSAID treatment must continue and the

patient has non-ulcer dyspepsia, use a

maintenance PPI dose

When Not to Refer for Endoscopy

  • Aged under 55 years and no alarm

signs

  • Not yet tested for H. pylori and

treated, if necessary

  • Recent normal endoscopy result but

persistent symptoms

  • Long established dyspepsia that has

not become worse over a period of

time

NB

  • Most GI ulcers are strongly

associated with H. pylori infection

  • 30% of endoscopy results are normal
  • 2% diagnose oesophago/gastric

cancer

  • Endoscopy is expensive

CHOICE OF PROTON PUMP INHIBITOR (PPI)

Acid Related Dyspepsia GORD

Prophylaxis of NSAID GU, DU or gastroduodenal erosions.

PUD

NSAID-induced GU, DU or gastroduodenal erosions.

Severe erosive GORD

Barrett’s oesophagus NG / PEG tubes / dysphagia

Lansoprazole 15mg or omeprazole 20mg capsule daily

Lansoprazole 15mg or omeprazole 20mg capsule daily

Lansoprazole 30mg or omeprazole 40mg (2x20mg) capsule daily

Lansoprazole 30mg capsule twice daily

Omeprazole 40mg (2x20mg) daily. Dose should not be reduced even if patient is asymptomatic. Ranitidine 150- 300mg and alginates can be added if necessary

Lansoprazole Orodispersible tablets 15mg-30mg daily

Review at 2 to 4 weeks. Consider stopping/ stepping down to H antagonists or alginates.

Review at 4 weeks, and then 8 weeks where necessary. Consider stopping or stepping down as before.

Review at 4 weeks, and then 8 weeks and consider maintenance dose of lansoprazole 15 -30mg daily.

Unable to step down.

Maintenance dose required.

Lansoprazole 30mg or omeprazole 40mg (2 x 20mg capsules) daily Review at intervals for step down or discontinuation

Lansoprazole 15mg or omeprazole 20mg capsule daily Review at intervals for step down or discontinuation

Appropriate lifestyle modifications such as diet, alcohol intake and smoking should always be encouraged

Note: Lansoprazole orodispersible tablets should be placed on the tongue, allowed to disperse and then swallowed, or dispersed in water and then swallowed / administered via a feeding tube.